Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease
Robert A Rissman · 2025
Read Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease by Robert A Rissman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710425.txt.
Description
Robert Rissman reports 2025 findings on blood tests that sort people by brain amyloid in preclinical Alzheimer's disease. A plasma ratio test for amyloid can predict raised brain amyloid on PET scans, and the team asked if adding tau measures makes that call sharper.
Samples came from more than a thousand people screening for a preclinical trial. Mass spectrometry measured amyloid and two forms of phosphorylated tau in plasma. Adding the phospho-tau217 ratio in particular lifted how well the blood test matched PET class. That gain could cut the cost and load of trial screening.
Catalog record
| CREATOR | Robert A Rissman |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |